Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
Bioinformatics challenges for genome-wide association studies.
Biologic therapies: lessons from multiple sclerosis.
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis.
FDA approval of Isentress (raltegravir)
Psychiatric symptoms in patients with multiple sclerosis.
Biomarkers in Multiple Sclerosis: An Up-to-Date Overview.
Expression and activation of human endogenous retroviruses of the W family in blood cells and astrocytes: implications for the pathogenesis of multiple sclerosis.
IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease.
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients.
Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MS.
Elevation of Ser9 phosphorylation of GSK3β is required for HERV-W env-mediated BDNF signaling in human U251 cells.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.

Pages